Literature DB >> 12399971

Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation.

V Pascal1, C Brunet, V Pradel, X Thirion, P Andre, C Faucher, J Sampol, F Dignat-George, D Blaise, E Vivier, C Chabannon.   

Abstract

We retrospectively analyzed the percentages and absolute numbers of T cells, natural killer (NK) cells and NK cell subsets in cryopreserved samples of either bone marrow or blood non-T cell-depleted allogeneic MHC-matched hematopoietic grafts. Using flow cytometry, we found higher numbers of NK cells in aphereses than in bone marrow collections. We further investigated the distribution of NK cell subsets, defined by the cell surface expression of MHC class I-specific receptors, in these allogeneic grafts. The distribution of NK cell subsets from the two different origins were similar, with the exception of the CD158a/h(+) NK cell subset, whose size appeared to be smaller in bone marrow. The search for relations between the numbers of infused cells and post-transplantation events demonstrated that increasing numbers of infused T cells but not NK cells are related with decreased overall survival. Our study highlights the toxicity of infused T cells but not NK cells in allogeneic MHC-matched hematopoietic grafts. These data pave the way for further trials to investigate the effect of NK cell infusion in MHC-matched allogeneic transplantation, and in particular whether ex vivo NK cell expansion and activation may enhance the anti-tumoral effect of the procedure and decrease its morbidity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399971     DOI: 10.1038/sj.leu.2402670

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

1.  Analysis of HLA class Ia transcripts in human leukaemias.

Authors:  Durjoy Majumder; Debasis Bandyopadhyay; Sarmila Chandra; Ashis Mukhopadhayay; Nandini Mukherjee; Subir K Bandyopadhyay; Subrata Banerjee
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

Review 2.  Manufacturing Natural Killer Cells as Medicinal Products.

Authors:  Christian Chabannon; Bechara Mfarrej; Sophie Guia; Sophie Ugolini; Raynier Devillier; Didier Blaise; Eric Vivier; Boris Calmels
Journal:  Front Immunol       Date:  2016-11-15       Impact factor: 7.561

3.  Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.

Authors:  Lia Minculescu; Anne Fischer-Nielsen; Eva Haastrup; Lars Peter Ryder; Niels Smedegaard Andersen; Ida Schjoedt; Lone Smidstrup Friis; Brian Thomas Kornblit; Søren Lykke Petersen; Henrik Sengelov; Hanne Vibeke Marquart
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

4.  Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.

Authors:  Lixia Sheng; Qitian Mu; Xiaoqing Wu; Shujun Yang; Huiling Zhu; Jiaping Wang; Yanli Lai; Hao Wu; Ye Sun; Yongxian Hu; Huarui Fu; Yi Wang; Kaihong Xu; Yongcheng Sun; Yanli Zhang; Ping Zhang; Miao Zhou; Binbin Lai; Zhijuan Xu; Minjie Gao; Yi Zhang; Guifang Ouyang
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.